Override rate of drug-drug interaction alerts in clinical decision support systems: A brief systematic review and meta-analysis
- PMID: 38899788
- DOI: 10.1177/14604582241263242
Override rate of drug-drug interaction alerts in clinical decision support systems: A brief systematic review and meta-analysis
Abstract
Primary studies have demonstrated that despite being useful, most of the drug-drug interaction (DDI) alerts generated by clinical decision support systems are overridden by prescribers. To provide more information about this issue, we conducted a systematic review and meta-analysis on the prevalence of DDI alerts generated by CDSS and alert overrides by physicians. The search strategy was implemented by applying the terms and MeSH headings and conducted in the MEDLINE/PubMed, EMBASE, Web of Science, Scopus, LILACS, and Google Scholar databases. Blinded reviewers screened 1873 records and 86 full studies, and 16 articles were included for analysis. The overall prevalence of alert generated by CDSS was 13% (CI95% 5-24%, p-value <0.0001, I^2 = 100%), and the overall prevalence of alert override by physicians was 90% (CI95% 85-95%, p-value <0.0001, I^2 = 100%). This systematic review and meta-analysis presents a high rate of alert overrides, even after CDSS adjustments that significantly reduced the number of alerts. After analyzing the articles included in this review, it was clear that the CDSS alerts physicians about potential DDI should be developed with a focus on the user experience, thus increasing their confidence and satisfaction, which may increase patient clinical safety.
Keywords: clinical decision support system; computerized physician order entry; drug-drug interactions; medication safety; systematic review; user experience.
Conflict of interest statement
Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.BMC Med Inform Decis Mak. 2022 Feb 22;22(1):48. doi: 10.1186/s12911-022-01783-z. BMC Med Inform Decis Mak. 2022. PMID: 35193547 Free PMC article.
-
Appropriateness of Overridden Alerts in Computerized Physician Order Entry: Systematic Review.JMIR Med Inform. 2020 Jul 20;8(7):e15653. doi: 10.2196/15653. JMIR Med Inform. 2020. PMID: 32706721 Free PMC article. Review.
-
Physicians' responses to computerized drug-drug interaction alerts for outpatients.Comput Methods Programs Biomed. 2013 Jul;111(1):17-25. doi: 10.1016/j.cmpb.2013.02.006. Epub 2013 Apr 19. Comput Methods Programs Biomed. 2013. PMID: 23608682
-
High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.J Am Med Inform Assoc. 2020 Jun 1;27(6):893-900. doi: 10.1093/jamia/ocaa034. J Am Med Inform Assoc. 2020. PMID: 32337561 Free PMC article.
-
A critical evaluation of clinical decision support for the detection of drug-drug interactions.Expert Opin Drug Saf. 2011 Nov;10(6):871-82. doi: 10.1517/14740338.2011.583916. Epub 2011 May 4. Expert Opin Drug Saf. 2011. PMID: 21542665 Review.
Cited by
-
Interactions Between Direct Oral Anticoagulants and Drugs Involving CYP-Enzymes and P-gp Transporters Detected by a Clinical Decision Support System: A Retrospective Cohort Study.Cardiovasc Drugs Ther. 2025 Apr 8. doi: 10.1007/s10557-025-07691-4. Online ahead of print. Cardiovasc Drugs Ther. 2025. PMID: 40198487
-
Pharmacotherapeutic actions related to drug interaction alerts - a questionnaire study among Swedish hospital interns and residents in family medicine.Eur J Clin Pharmacol. 2025 Feb;81(2):301-308. doi: 10.1007/s00228-024-03785-4. Epub 2024 Dec 16. Eur J Clin Pharmacol. 2025. PMID: 39680076 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical